Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Tobias Rautio

7PUBLICATIONS

19CO-AUTHORS

Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsMedical biochemistry - proteins and peptides (incl. medical proteomics)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|May 23, 2025

Tail-less precursors in synthetic cannabinoid production: investigating a clandestine laboratory, seized samples, and CB<sub>1</sub> activity.

Manuela Carla Monti, Tobias Rautio, Marie H Deventer

|May 20, 2025

Structure-metabolism relationships of 4-pentenyl synthetic cannabinoid receptor agonists using in vitro human hepatocyte incubations and high-resolution mass spectrometry.

Steven R Baginski, Karin Lindbom, Bryan Valencia Crespo

|May 18, 2025

In vitro CB<sub>1</sub> receptor activity of halogenated indazole synthetic cannabinoid receptor agonists.

Henrik Green, Craig McKenzie, Elias Hamra

|Jul 23, 2024

In vitro metabolism study of ADB-P-5Br-INACA and ADB-4en-P-5Br-INACA using human hepatocytes, liver microsomes, and in-house synthesized references.

Tobias Rautio, Robin Obrist, Lucas Krebs

|May 28, 2024

Human metabolism of the semi-synthetic cannabinoids hexahydrocannabinol, hexahydrocannabiphorol and their acetates using hepatocytes and urine samples.

Karin Lindbom, Caitlyn Norman, Steven Baginski

|Sep 25, 2023

The metabolic profile of the synthetic cannabinoid receptor agonist ADB-HEXINACA using human hepatocytes, LC-QTOF-MS and synthesized reference standards.

Steven R Baginski, Tobias Rautio, Lorna A Nisbet

Pageof 2

Frequent Collaborators

7 joint publications

Henrik Gréen

4 joint publications

Xiongyu Wu

4 joint publications

Craig McKenzie

3 joint publications

Steven R Baginski

3 joint publications

Caitlyn Norman

2 joint publications

Lorna A Nisbet

2 joint publications

Manuela Carla Monti

1 joint publications

Shimpei Watanabe

1 joint publications

Lucas Krebs

1 joint publications

Darta Stalberga

Frequent Collaborators

7 joint publications

Henrik Gréen

4 joint publications

Xiongyu Wu

4 joint publications

Craig McKenzie

3 joint publications

Steven R Baginski

Top Related Videos

Fentanyl Analog Screening using LC-TIMS-TOF MS/MS

Fentanyl Analog Screening using LC-TIMS-TOF MS/MS

Published on : Nov 08, 2024

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Published on : Mar 28, 2017

An <em>In vitro</em> FluoroBlok Tumor Invasion Assay

An <em>In vitro</em> FluoroBlok Tumor Invasion Assay

Published on : Jul 20, 2009

See more related videos

Top Related Videos

Fentanyl Analog Screening using LC-TIMS-TOF MS/MS

Fentanyl Analog Screening using LC-TIMS-TOF MS/MS

Published on : Nov 08, 2024

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Published on : Mar 28, 2017

An <em>In vitro</em> FluoroBlok Tumor Invasion Assay

An <em>In vitro</em> FluoroBlok Tumor Invasion Assay

Published on : Jul 20, 2009

See more related videos